Form 4: Elanco Animal Health Executive Grace McArdle Reports Stock Transactions
SEC Form 4 Filing
EVP Grace McArdle reports acquisition of 8,025 shares and disposition of 2,596 shares of Elanco Animal Health Inc. common stock.
Summary
- Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 19, 2025, McArdle acquired 8,025 shares of common stock at $0.
- On the same day, McArdle disposed of 2,596 shares at $11.24.
- Following these transactions, McArdle beneficially owns 55,641 shares of Elanco common stock directly.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock transactions.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of stock acquisition and disposition. |
| 02/21/2025 | Date of Form 4 signature. |
Keywords
Form 4, Beneficial Ownership, Elanco Animal Health, Stock Transaction, Insider Trading, Equity Securities, McArdle, ELAN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.